+

WO2007030391A3 - Procede de diagnostic d'infections - Google Patents

Procede de diagnostic d'infections Download PDF

Info

Publication number
WO2007030391A3
WO2007030391A3 PCT/US2006/034287 US2006034287W WO2007030391A3 WO 2007030391 A3 WO2007030391 A3 WO 2007030391A3 US 2006034287 W US2006034287 W US 2006034287W WO 2007030391 A3 WO2007030391 A3 WO 2007030391A3
Authority
WO
WIPO (PCT)
Prior art keywords
organism
antigens
diagnosing infections
animal
free surface
Prior art date
Application number
PCT/US2006/034287
Other languages
English (en)
Other versions
WO2007030391A2 (fr
Inventor
C A Speer
Shigetoshi Eda
Original Assignee
Univ Tennessee Res Foundation
C A Speer
Shigetoshi Eda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tennessee Res Foundation, C A Speer, Shigetoshi Eda filed Critical Univ Tennessee Res Foundation
Priority to CA2621485A priority Critical patent/CA2621485C/fr
Priority to AU2006287702A priority patent/AU2006287702A1/en
Priority to JP2008530117A priority patent/JP2009507243A/ja
Priority to BRPI0615678-9A priority patent/BRPI0615678A2/pt
Priority to EP06814088A priority patent/EP1928614A4/fr
Publication of WO2007030391A2 publication Critical patent/WO2007030391A2/fr
Publication of WO2007030391A3 publication Critical patent/WO2007030391A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Elimination d'antigènes à la surface d'un organisme, du type micro-organisme, sans perturbation de l'organisme et libération d'antigènes internes de l'organisme, processus encore appelé « délogement souple » des antigènes à partir des organismes considérés. Les antigènes de surface libres de l'organisme peuvent servir à déterminer la présence d'une infection chez un animal imputable à l'organisme, par détermination de la présence d'anticorps qui se lient avec les antigènes de surface libres dans un échantillon prélevé sur l'animal.
PCT/US2006/034287 2005-09-06 2006-09-05 Procede de diagnostic d'infections WO2007030391A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA2621485A CA2621485C (fr) 2005-09-06 2006-09-05 Procede pour le diagnostic d'infections a l'aide d'antigenes de surface obtenus sans perturber de cellules
AU2006287702A AU2006287702A1 (en) 2005-09-06 2006-09-05 Method for diagnosing infections
JP2008530117A JP2009507243A (ja) 2005-09-06 2006-09-05 感染症を診断する方法
BRPI0615678-9A BRPI0615678A2 (pt) 2005-09-06 2006-09-05 método para diagnosticar infecções
EP06814088A EP1928614A4 (fr) 2005-09-06 2006-09-05 Procede de diagnostic d'infections

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/220,156 US7713715B2 (en) 2005-09-06 2005-09-06 Method for diagnosing infections
US11/220,156 2005-09-06

Publications (2)

Publication Number Publication Date
WO2007030391A2 WO2007030391A2 (fr) 2007-03-15
WO2007030391A3 true WO2007030391A3 (fr) 2007-09-20

Family

ID=37830465

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/034287 WO2007030391A2 (fr) 2005-09-06 2006-09-05 Procede de diagnostic d'infections

Country Status (7)

Country Link
US (1) US7713715B2 (fr)
EP (1) EP1928614A4 (fr)
JP (1) JP2009507243A (fr)
AU (1) AU2006287702A1 (fr)
BR (1) BRPI0615678A2 (fr)
CA (1) CA2621485C (fr)
WO (1) WO2007030391A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070062460A1 (en) * 2005-09-21 2007-03-22 Robert Simer Swine saliva sampling method
CN101952728B (zh) * 2008-02-01 2016-05-11 圣诺菲·帕斯图尔有限公司 用于诊断肺炎链球菌的试验
DE102008029834A1 (de) * 2008-06-25 2010-01-14 Justus-Liebig-Universität Giessen Verfahren zum spezifischen Nachweis von MAP-Antikörpern
WO2010010914A1 (fr) * 2008-07-23 2010-01-28 オリンパス株式会社 Procédé de collecte d'acide nucléique à partir d'un échantillon fécal, procédé d'analyse d'acide nucléique et appareil pour le traitement d'échantillon fécal
US9696304B2 (en) 2012-01-27 2017-07-04 University Of Tennessee Research Foundation Methods for detecting a biomarker by alternating current electrokinetics
JP6185935B2 (ja) 2012-01-27 2017-08-23 ユニバーシティ オブ テネシー リサーチ ファウンデーション 交流動電によるバイオマーカーの検出のための方法および装置
CA2988297A1 (fr) 2016-12-28 2018-06-28 University Of Tennessee Research Foundation Methodes de detection d'un biomarqueur par electrocinetique de courant alternatif
US20180265887A1 (en) 2017-03-16 2018-09-20 Jacobs Farm Del Cabo Basil Plants With High Tolerance to Downy Mildew
US11252928B2 (en) 2017-09-21 2022-02-22 The Condard-Pyle Company Miniature rose plant named ‘Meibenbino’
US11917978B2 (en) 2017-09-21 2024-03-05 The Conard Pyle Company Miniature rose plant named ‘meibenbino’
US20200348300A1 (en) * 2018-01-18 2020-11-05 The Penn State Research Foundation Mycobacterium avium subspecies paratuberculosis immunodiagnostic antigens, methods, and kits comprising same
US11944063B2 (en) 2020-09-30 2024-04-02 Spring Meadow Nursery, Inc. Hydrangea ‘SMNHPH’
US11155884B1 (en) 2020-10-16 2021-10-26 Klemm & Sohn Gmbh & Co. Kg Double-flowering dwarf Calibrachoa
EP3984355B1 (fr) 2020-10-16 2024-05-15 Klemm & Sohn GmbH & Co. KG Calibrachoa nain à double floraison

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020064801A1 (en) * 1999-12-01 2002-05-30 Ryan Jeffrey R. Novel and practical serological assay for the clinical diagnosis of leishmaniasis
US6926898B2 (en) * 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139840B4 (de) * 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
US6592877B1 (en) * 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
JP3864230B2 (ja) * 2003-09-26 2006-12-27 独立行政法人農業・食品産業技術総合研究機構 ヨーネ菌抗原タンパク質、該タンパク質をコードする遺伝子、及び該タンパク質を用いるヨーネ病の診断方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020064801A1 (en) * 1999-12-01 2002-05-30 Ryan Jeffrey R. Novel and practical serological assay for the clinical diagnosis of leishmaniasis
US6926898B2 (en) * 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DEKESEL ET AL.: "cloning and Expression of Portions of the 34-Kilodalton protein Gene of Mycobacterium paratuberculosis", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 3, no. 4, April 1993 (1993-04-01), pages 947 - 954, XP008126639 *

Also Published As

Publication number Publication date
CA2621485A1 (fr) 2007-03-15
AU2006287702A1 (en) 2007-03-15
WO2007030391A2 (fr) 2007-03-15
EP1928614A4 (fr) 2009-06-17
CA2621485C (fr) 2013-01-15
US7713715B2 (en) 2010-05-11
JP2009507243A (ja) 2009-02-19
BRPI0615678A2 (pt) 2011-05-24
US20070054334A1 (en) 2007-03-08
EP1928614A2 (fr) 2008-06-11

Similar Documents

Publication Publication Date Title
WO2007030391A3 (fr) Procede de diagnostic d'infections
WO2006086561A3 (fr) Neutralisation d'anticorps monoclonaux contre le coronavirus associe au syndrome respiratoire aigu severe
MX2008007716A (es) Metodo para eliminar extra corporalmente de la sangre un microbio patogeno, una celula inflamatoria o una proteina inflamatoria.
WO2007051077A3 (fr) Methodes et composes de detection et d'isolement de cellules lymphomatiques
MY157955A (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
PT1322960E (pt) Ensaio de micro-arranjos de alergenios
WO2006088597A3 (fr) Proteine circumsporozoite hybride de plasmodium vivax et son vaccin
EP2412725A3 (fr) Anticorps contre le CD79b pour le traitement de tumeurs d'origine hématopoïétique
WO2009070507A3 (fr) Antigènes d'anaplasma phagocytophilum (aph) et anticorps spécifiques des anaplasmes
WO2006098621A3 (fr) Structure beta croisee dans des organismes microbiens
WO2006107611A3 (fr) Detection d'une reponse immunitaire contre les agents de modulation gdf-8
WO2005080985A3 (fr) Methodes et compositions permettant de detecter et de traiter des maladies auto-immunes
WO2008081938A1 (fr) Utilisation d'une protéine thermostable de liaison à la biotine et support solide ayant la protéine liée à celui-ci
WO2006059247A3 (fr) Anti-infectieux a base de proteine isd pour une infection a staphylococcus aureus
WO2004102199A3 (fr) Procede de selection et de production de composants de vaccins, et vaccins derives de ceux-ci
WO2007015177A3 (fr) Procede et trousse de diagnostic in vitro pour infection a aspergillus
EA200700345A1 (ru) Обогащённое антитело для выявления микобактериальной инфекции, способы применения и диагностические тесты, применяющие такое антитело
WO2012051372A3 (fr) Antigènes immunoréactifs de mycoplasma haemofelis et immunoessai diagnostique
EP2527357A3 (fr) Analyseur de diagnostic
WO2006046979A3 (fr) Peritonite infectieuse feline (fip) et biomarqueurs pour coronavirus multi-organes systemiques, et procedes de criblage
WO2006067792A3 (fr) Autoantigenes de l'aldolase utiles pour le diagnostic et le traitement de la maladie d'alzheimer
WO2004029216A3 (fr) Diagnostic d'une infection a moisissures invasives
WO2003033530A3 (fr) Antigenes mycobacteriens exprimes a haute tension en oxygene
WO2010053772A3 (fr) Antigènes associés à une maladie et leurs procédés d'utilisation
WO2007054537A8 (fr) Nouvelle bactérie et vaccin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006814088

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2621485

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2008530117

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 566643

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2006287702

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2006287702

Country of ref document: AU

Date of ref document: 20060905

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: PI0615678

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080305

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载